Top

Journal of Autism and Developmental Disorders

Gepubliceerd in:

14-09-2015 | Original Paper

Autism Spectrum Disorder Risk in Relation to Maternal Mid-Pregnancy Serum Hormone and Protein Markers from Prenatal Screening in California

Auteurs: Gayle C. Windham, Kristen Lyall, Meredith Anderson, Martin Kharrazi

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 2/2016

Abstract

We examined prenatal screening markers and offspring autism spectrum disorder (ASD) using California statewide data on singleton births in 1996 and 2002. Second trimester levels of unconjugated estriol (uE3), human chorionic gonadotropin (hCG), and maternal serum alpha-fetoprotein (MSAFP) were compared between mothers of children with ASD (n = 2586) and of non-cases (n = 600,103). Adjusted odds ratios (AOR) were calculated by logistic regression. Lower uE3 (AOR for < 10th percentile vs. 25th–74th percentiles = 1.21, 95 % CI 1.06–1.37), and higher MSAFP (AOR = 1.21, 95 % CI 1.07–1.37 for > 90th percentile) were significantly associated with ASD. A U-shaped relationship was seen for hCG (AOR = 1.16, 95 % CI 1.02–1.32 for < 10th percentile; AOR = 1.19, 95 % CI 1.05–1.36 for > 90th percentile). Our results further support prenatal hormone involvement in ASD risk.

vorige artikel Longitudinal Examination of Adaptive Behavior in Autism Spectrum Disorders: Influence of Executive Function

volgende artikel Does the cognitive architecture of simplex and multiplex ASD families differ?

Alleen toegankelijk voor geautoriseerde gebruikers

Abdallah, M. W., Grove, J., Hougaard, D. M., Norgaard-Pedersen, B., Ibrahimov, F., & Mortensen, E. L. (2011). Autism spectrum disorders and maternal serum alpha-fetoprotein levels during pregnancy. Canadian Journal of Psychiatry, 56, 727–734.PubMed

Andersen, S. L., Laurberg, P., Wu, C. S., & Olsen, J. (2014). Attention deficit hyperactivity disorder and autism spectrum disorder in children born to mothers with thyroid dysfunction: A Danish Nationwide Cohort Study. BJOG, 121, 1365–1374. doi:10.1111/1471-0528.12681.CrossRefPubMed

Ashwood, P., Wills, S., & Van de Water, J. (2006). The immune response in autism: A new frontier for autism research. Journal of Leukocyte Biology, 80, 1–15.CrossRefPubMed

Auyeung, B., Baron-Cohen, S., Ashwin, E., Knickmeyer, R., Taylor, K., & Hackett, G. (2009). Fetal testosterone and autistic traits. British Journal of Psychology, 100, 1–22.CrossRefPubMed

Baron-Cohen, S. (2002). The extreme male brain theory of autism. Trends in Cognitive Sciences, 6, 248–254.CrossRefPubMed

Baron-Cohen, S., Auyeung, B., Norgaard-Pedersen, B., Hougaard, D. M., Abdallah, M. W., Melgaard, L., et al. (2014). Elevated fetal steroidogenic activity in autism. Molecular Psychiatry, 20(3), 369–376. doi:10.1038/mp.2014.48.PubMedCentralCrossRefPubMed

Baron-Cohen, S., Knickmeyer, R., & Belmonte, M. K. (2005). Sex differences in the brain: Implications for explaining autism. Science, 310, 819–823.CrossRefPubMed

Benn, P. A., Horne, D., Briganti, S., Rodis, J. F., & Clive, J. M. (1996). Elevated second-trimester maternal serum Hcg alone or in combination with elevated alpha-fetoprotein. Obstetrics and Gynecology, 87, 217–222. doi:10.1016/0029-7844(95)00390-8.CrossRefPubMed

Beyer, C. (1999). Estrogen and the developing mammalian brain. Anatomy and Embryology (Berl), 199, 379–390.CrossRef

Canick, J. A., & MacRae, A. R. (2005). Second Trimester Serum Markers. Seminars in Perinatology, 29, 203–208. doi:10.1053/j.semperi.2005.05.011.CrossRefPubMed

Centers for Disease Control and Prevention (CDC). (2014). Prevalence of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2010. MMWR Surveillance Summaries, 63, 1–21.

Cunningham, G. C., & Tompkinison, D. G. (1999). Cost and effectiveness of the California triple marker prenatal screening program. Genet Med, 1, 199–206. doi:10.1097/00125817-199907000-00006.CrossRefPubMed

Gardener, H., Spiegelman, D., & Buka, S. L. (2009). Prenatal risk factors for autism: Comprehensive meta-analysis. British Journal of Psychiatry, 195, 7–14. doi:10.1192/bjp.bp.108.051672.PubMedCentralCrossRefPubMed

Gardener, H., Spiegelman, D., & Buka, S. L. (2011). Perinatal and neonatal risk factors for autism: A comprehensive meta-analysis. Pediatrics, 128, 344–355.PubMedCentralCrossRefPubMed

Geschwind, N., & Behan, P. (1982). Left-handedness: Association with immune disease, migraine, and developmental learning disorder. Proceedings of National Academy of Sciences, 79, 5097–5100.CrossRef

Geschwind, N., & Behan, P. (1984). Laterality, hormones and immunity. In N. Geschwind & A. M. Galaburda (Eds.), Cerebral dominance: The biological foundations (pp. 211–224). USA: Harvard University Press.

Gesundheit, B., Rosenzweig, J. P., Naor, D., Lerer, B., Zachor, D. A., Prochazka, V., et al. (2013). Immunological and Autoimmune considerations of autism spectrum disorders. Journal of Autoimmunity, 44, 1–7. doi:10.1016/j.jaut.2013.05.005.CrossRefPubMed

Goines, P., & Van de Water, J. (2010). The immune system’s role in the biology of autism. Current Opinion in Neurology, 23, 111–117. doi:10.1097/WCO.0b013e3283373514.PubMedCentralCrossRefPubMed

Gore, A. C., Martien, K. M., Gagnidze, K., & Pfaff, D. (2014). Implications of prenatal steroid perturbations for neurodevelopment, behavior, and autism. Endocrine Reviews, 35(6), 961–991. doi:10.1210/er.2013-1122.PubMedCentralCrossRefPubMed

Graves, J. C., Miller, K. E., & Sellers, A. D. (2002). Maternal serum triple analyte screening in pregnancy. American Family Physician, 65, 915–920.PubMed

Grether, J. K., Anderson, M., Croen, L. A., Smith, D., & Windham, G. C. (2009). Risk of autism and increasing maternal and paternal age in a large North American population. American Journal of Epidemiology, 170, 1118–1126.CrossRefPubMed

Grether, J. K., Qian, Y., Croughan, M. S., Wu, Y. W., Schembri, M., Camarano, L., et al. (2013). Is infertility associated with childhood autism? Journal of Autism and Developmental Disorders, 43, 663–672. doi:10.1007/s10803-012-1598-5.CrossRefPubMed

Hallmayer, J., Cleveland, S., Torres, A., Phillips, J., Cohen, B., Torigoe, T., et al. (2011). Genetic heritability and shared environmental factors among twin pairs with autism. Archives of General Psychiatry, 68(11), 1095–1102. doi:10.1001/archgenpsychiatry.2011.76.PubMedCentralCrossRefPubMed

Hertz-Picciotto, I., Croen, L., Hansen, R., Jones, C., van de Water, J., & In, P. (2006). The charge study: An epidemiologic investigation of genetic and environmental factors contributing to autism. Environmental Health Perspectives, 114, 1119–1125.PubMedCentralCrossRefPubMed

Hertz-Picciotto, I., & Delwiche, L. (2009). The rise in autism and the role of age at diagnosis. Epidemiology, 20, 84–90.PubMedCentralCrossRefPubMed

Hvidtjorn, D., Grove, J., Schendel, D., Schieve, L. A., Svaerke, C., Ernst, E., et al. (2011). Risk of autism spectrum disorders in children born after assisted conception: A population-based follow-up study. Journal of Epidemiology and Community Health, 65, 497–502. doi:10.1136/jech.2009.093823.CrossRefPubMed

Jelliffe-Pawlowski, L. L., Baer, R. J., & Currier, R. J. (2010). Second trimester serum predictors of preterm birth in a population-based sample of low-risk pregnancies. Prenatal Diagnosis, 30, 727–733. doi:10.1002/pd.2489.CrossRefPubMed

Kajta, M., & Beyer, C. (2003). Cellular strategies of estrogen-mediated neuroprotection during brain development. Endocrine, 21, 3–9. doi:10.1385/endo:21:1:3.CrossRefPubMed

Kayisli, U. A., Selam, B., Guzeloglu-Kayisli, O., Demir, R., & Arici, A. (2003). Human chorionic gonadotropin contributes to maternal immunotolerance and endometrial apoptosis by regulating Fas–Fas ligand system. J Immunol, 171, 2305–2313.CrossRefPubMed

King, M., & Bearman, P. (2009). Diagnostic change and the increased prevalence of autism. International Journal of Epidemiology, 38, 1224–1234.PubMedCentralCrossRefPubMed

Knickmeyer, R., Baron-Cohen, S., Raggatt, P., Taylor, K., & Hackett, G. (2006). Fetal testosterone and empathy. Hormones and Behavior, 49, 282–292.CrossRefPubMed

Krakowiak, P., Walker, C. K., Bremer, A. A., Baker, A. S., Ozonoff, S., Hansen, R. L., et al. (2012). Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders. Pediatrics, 129, e1121–e1128. doi:10.1542/peds.2011-2583.PubMedCentralCrossRefPubMed

Kratzer, P. G., & Taylor, R. N. (1990). Corpus luteum function in early pregnancies is primarily determined by the rate of change of human chorionic gonadotropin levels. American Journal of Obstetrics and Gynecology, 163, 1497–1502.CrossRefPubMed

Kulch, P., Keener, S., Matsumoto, M., & Crandall, B. F. (1993). Racial differences in maternal serum human chorionic gonadotropin and unconjugated oestriol levels. Prenatal Diagnosis, 13, 191–195.CrossRefPubMed

Larsson, H., Eaton, W., Madsen, K., Vestergaard, M., Olesen, A., Agerbo, E., et al. (2005). Risk factors for autism: Perinatal factors, parental psychiatric history, and socioeconomic status. American Journal of Epidemiology, 161, 916–925.CrossRefPubMed

Lutchmaya, S., Baron-Cohen, S., Raggatt, P., Knickmeyer, R., & Manning, J. T. (2004). 2nd to 4th digit ratios, fetal testosterone and estradiol. Early Human Development, 77, 23–28.CrossRefPubMed

Lyall, K., Pauls, D. L., Santangelo, S., Spiegelman, D., & Ascherio, A. (2010). Maternal early life factors associated with hormone levels and the risk of having a child with an autism spectrum disorder in the nurses’ health study II. Journal of Autism and Developmental Disorders, 41, 618–627.CrossRef

Lyall, K., Pauls, D. L., Spiegelman, D., Santangelo, S. L., & Ascherio, A. (2012). Fertility therapies, infertility and autism spectrum disorders in the nurses’ health study II. Paediatric and Perinatal Epidemiology, 26, 361–372. doi:10.1111/j.1365-3016.2012.01294.x.PubMedCentralCrossRefPubMed

Manning, J. T., Baron-Cohen, S., Wheelwright, S., & Sanders, G. (2001). The 2nd to 4th digit ratio and autism. Developmental Medicine and Child Neurology, 43, 160–164.CrossRefPubMed

Manning, J. T., Scutt, D., Wilson, J., & Lewis-Jones, D. I. (1998). The Ratio of 2nd to 4th digit length: A predictor of sperm numbers and concentrations of testosterone, luteinizing hormone and oestrogen. Human Reproduction, 13, 3000–3004.CrossRefPubMed

Markestad, T., Bergsjo, P., Aakvaag, A., Lie, R. T., Jacobsen, G., Hoffman, H. J., et al. (1997). Prediction of fetal growth based on maternal serum concentrations of human chorionic gonadotropin, human placental lactogen and estriol. Acta Obstetricia Supplement, 165, 50–55.

McCruden, A. B., & Stimson, W. H. (1991). Sex hormones and immune function. In R. Ader, D. Felton, & N. Cohen (Eds.), Psychoneuroimmunology (pp. 475–493). San Diego: Academic.

Mizejewski, G. J. (2007). Physiology of alpha-fetoprotein as a biomarker for perinatal distress: Relevance to adverse pregnancy outcome. Experimental Biology and Medicine (Maywood, N.J.) 232, 993–1004. doi:10.3181/0612-mr-291.

Newschaffer, C. J., Croen, L. A., Daniels, J., Giarelli, E., Grether, J. K., Levy, S. E., et al. (2007). The epidemiology of autism spectrum disorders. Annual Review of Public Health, 28, 235–258.CrossRefPubMed

Pergament, E., Stein, A. K., Fiddler, M., Cho, N. H., & Kupferminc, M. J. (1995). Adverse pregnancy outcome after a false-positive screen for down syndrome using multiple markers. Obstetrics and Gynecology, 86, 255–258.CrossRefPubMed

Puntachai, P., Wanapirak, C., Sirichotiyakul, S., Tongprasert, F., Srisupundit, K., Luewan, S., et al. (2014). Associations between pregnancy outcomes and unexplained high and low maternal serum alpha-fetoprotein levels. Archives Gynecology Obstetrics. doi:10.1007/s00404-014-3606-9.

Sandin, S., Hultman, C. M., Kolevzon, A., Gross, R., MacCabe, J. H., & Reichenberg, A. (2012). Advancing maternal age is associated with increasing risk for autism: A review and meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry, 51(477–486), e471. doi:10.1016/j.jaac.2012.02.018.

Schleifer, R. A., Bradley, L. A., Richards, D. S., & Ponting, N. R. (1995). Pregnancy outcome for women with very low levels of maternal serum unconjugated estriol on second-trimester screening. American Journal of Obstetrics and Gynecology, 173, 1152–1156.CrossRefPubMed

Spencer, K. (2000). The influence of fetal sex in screening for down syndrome in the second trimester using Afp and free Beta-Hcg. Prenatal Diagnosis, 20, 648–651.CrossRefPubMed

Sweeten, T. L., Bowyer, S. L., Posey, D. J., Halberstadt, G. M., & McDougle, C. J. (2003). Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics, 112, e420–e424.CrossRefPubMed

Tache, V., Baer, R. J., Currier, R. J., Li, C. S., Towner, D., Waetjen, L. E., et al. (2014). Population-based biomarker screening and the development of severe preeclampsia in California. American Journal of Obstetrics & Gynecology, 211, 377.e371–e378. doi:10.1016/j.ajog.2014.03.026.

Teatero, M. L., & Netley, C. (2013). A critical review of the research on the extreme male brain theory and digit ratio (2d:4d). Journal of Autism and Developmental Disorders, 43, 2664–2676. doi:10.1007/s10803-013-1819-6.CrossRefPubMed

Toran-Allerand, C. D. (1984). On the genesis of sexual differentiation of the general nervous system: Morphogenetic consequences of steroidal exposure and possible role of alpha-fetoprotein. Progress in Brain Research, 61, 63–98.CrossRefPubMed

Toran-Allerand, C. D. (1996). Mechanisms of estrogen action during neural development: Mediation by interactions with the neurotrophins and their receptors? Journal of Steroid Biochemistry and Molecular Biology, 56, 169–178.CrossRefPubMed

Toran-Allerand, C. D., Singh, M., & Sétáló, G, Jr. (1999). Novel mechanisms of estrogen action in the brain: New players in an old story. Frontiers in Neuroendocrinology, 20, 97–121.CrossRefPubMed

Wald, N. J., Kennard, A., Hackshaw, A., & McGuire, A. (1998). Antenatal screening for down’s syndrome. Health Technology Assessment (Winchester, England) 2 (i–iv), 1–112.

Waller, D. K., Lustig, L. S., Smith, A. H., & Hook, E. B. (1993). Alpha-fetoprotein: A biomarker for pregnancy outcome. Epidemiology, 4, 471–476.CrossRefPubMed

Windham, G. C., Anderson, M. C., Croen, L. A., Smith, K. S., Collins, J., & Grether, J. K. (2010). Birth prevalence of autism spectrum disorders in the San Francisco Bay area by demographic and ascertainment source characteristics. Journal of Autism and Developmental Disorders, 41, 1362–1372. doi:10.1007/s10803-010-1160-2.CrossRef

Titel: Autism Spectrum Disorder Risk in Relation to Maternal Mid-Pregnancy Serum Hormone and Protein Markers from Prenatal Screening in California
Auteurs: Gayle C. Windham
Kristen Lyall
Meredith Anderson
Martin Kharrazi
Publicatiedatum: 14-09-2015
Uitgeverij: Springer US
Gepubliceerd in: Journal of Autism and Developmental Disorders / Uitgave 2/2016
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI: https://doi.org/10.1007/s10803-015-2587-2

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 2/2016

Low Fidelity Imitation of Atypical Biological Kinematics in Autism Spectrum Disorders Is Modulated by Self-Generated Selective Attention

Brief Report: Recruitment and Retention of Minority Children for Autism Research

Siblings of Youth with Autism Spectrum Disorders: Theoretical Perspectives on Sibling Relationships and Individual Adjustment

Prevalence and Correlates of Educational Intervention Utilization Among Children with Autism Spectrum Disorder

Nutritional Impact of a Gluten-Free Casein-Free Diet in Children with Autism Spectrum Disorder

Emotion Perception or Social Cognitive Complexity: What Drives Face Processing Deficits in Autism Spectrum Disorder?